Skip to content
    UNH
    Earnings call· Dec 2025(Q4 FY25)

    UNITEDHEALTH GROUP INC UNH

    Jan 27, 2026 Source

    Executive summary

    UnitedHealth Group Q4 FY25 — Strategic Refocus and Margin Recovery

    UnitedHealth Group concluded FY25 slightly ahead of adjusted EPS expectations despite a significant $1.6 billion charge related to Optum restructuring and cyberattack impacts. The company is strategically refocusing its businesses, particularly Optum Health, and repricing its insurance segments for margin recovery in 2026, which will lead to membership contraction in Medicare Advantage, Medicaid, and Commercial. Management is confident in long-term growth driven by AI-enabled productivity, value-based care, and thoughtful capital stewardship, despite ongoing regulatory pressures and elevated medical cost trends.

    Highlights

    5
    • Adjusted earnings per share reached $16.35 for FY25, slightly ahead of expectations.

    • Full year 2025 revenues were nearly $448 billion, reflecting 12% growth from 2024.

    • The medical care ratio for FY25 was 89.1%, slightly better than expectations.

    • Anticipated operating cost reductions of nearly $1 billion in 2026, many AI-enabled.

    • OptumRx secured over 800 new customer relationships for 2026 and 2027.

    Concerns

    5
    • Full year 2025 results included a $1.6 billion net-of-tax charge ($1.78 per share) primarily for Optum restructuring, cyberattack-related activities, and loss contract reserves.

    • UnitedHealthcare expects Medicare Advantage membership contraction of 1.3 million to 1.4 million members for FY26.

    • Medicaid membership is expected to contract by 565,000 to 715,000 people in FY26.

    • Total UnitedHealthcare membership is projected to contract by 2.3 million to 2.8 million in FY26.

    • The 2027 Medicare Advance Notice is deemed "disappointing," implying "meaningful benefit reductions" and potential for reduced choice/access for seniors.

    Guidance & targets

    20
    CategoryTargetConfidence
    Adjusted earnings per share
    greater than $17.75
    high materiality
    High
    Revenues
    approximately $440 billion
    high materiality
    High
    Net earnings per share
    at least $17.10 per share
    high materiality
    High
    Operating cash flow
    at least $18 billion
    medium materiality
    High
    Medical care ratio
    88.8%
    high materiality
    High
    Operating cost ratio
    12.8%
    medium materiality
    High
    UnitedHealthcare Medicare Advantage membership contraction
    1.3 million to 1.4 million members
    high materiality
    High
    Medicaid membership contraction
    565,000 to 715,000 people
    high materiality
    High
    Total UnitedHealthcare membership contraction
    2.3 million to 2.8 million
    high materiality
    High
    UnitedHealthcare adjusted operating earnings growth
    approximately 13%
    high materiality
    High
    UnitedHealthcare operating earnings margins expansion
    40 basis points
    high materiality
    High
    OptumRx operating earnings growth
    modest 2%
    medium materiality
    High
    OptumRx margin expansion
    approximately 20 basis points
    medium materiality
    High
    Optum Insight earnings growth
    greater than 4%
    medium materiality
    High
    Optum Insight margin expansion
    approximately 90 basis points
    medium materiality
    High
    Optum Health operating earnings growth
    approximately 9%
    high materiality
    High
    Optum Health margin expansion
    approximately 30 basis points
    high materiality
    High
    Operating cost reductions (AI-enabled)
    nearly $1 billion
    medium materiality
    High
    Long-term debt-to-capital target
    approximately 40%
    medium materiality
    High
    AI/Technology investment
    nearly $1.5 billion
    medium materiality
    High

    Segment performance

    4
    SegmentRevenueYoYQoQMargin
    UnitedHealthcare
    Repriced insurance businesses for margin recovery, leading to planned membership contraction. Medicare margins expected to improve. Commercial pricing aligned with increased care activity. Expected to operate slightly below historical margin range until 2027.
    Medicare Advantage contraction: 1.3 million to 1.4 million members (FY26)Medicaid membership contraction: 565,000 to 715,000 people (FY26)Total membership contraction: 2.3 million to 2.8 million (FY26)Medicare margins improvement: approximately 50 basis points from 2025
    approximately 13% adjusted operating earnings growthoperating earnings margins expansion of 40 basis points
    OptumRx
    Strong external selling season, offsetting UHC membership contraction. Implementing new pricing models for transparency and cost-based reimbursement. Expected to return to high single-digit to low double-digit earnings growth long-term.
    New customer relationships: over 800 (impacting 2026 and 2027)Rebate pass-through: 100% to customers by end of 2027 (95% elected for 2026)Prior authorizations reduced: >10% (by removing reauthorization for 180 drugs)
    modest 2% earnings growthexpanding margins by approximately 20 basis points
    Optum Insight
    Growth driven by new sales, product commercialization, cost management, and increased volumes. Aligned Optum Financial Services with Optum Insight for greater synergy and innovation.
    earnings growth of greater than 4%expanding margins by approximately 90 basis points
    Optum Health
    Refocusing on integrated value-based care, optimizing network, and improving operational disciplines. Modest basis point improvement in 2026, building momentum for 2027. Long-term target margins of 6% to 8% still intact.
    Affiliated network narrowed: nearly 20%Risk membership streamlined: approximately 15%Employed provider groups on strategic EMRs: nearly 100% (down from 18 EMRs)
    operating earnings growth of approximately 9%expanding margins by approximately 30 basis points

    Operational metrics

    17
    Revenue
    $448 billion12% growth from 2024
    FY25

    Reflects continued solid execution across the enterprise.

    Medical care ratio
    89.1%slightly better than expectations
    FY25

    Includes approximately 20 basis points of negative charge-related impacts, primarily associated with loss contract reserve.

    Operating cost ratio
    13.3%slightly higher than anticipated
    FY25

    Demonstrates strong management discipline while balancing key investments. Higher than anticipated due to charge-related impacts and employee incentives/funding.

    Adjusted EPS
    $16.35slightly ahead of expectations
    FY25

    Reported adjusted earnings per share for the full year.

    Net-of-tax charge
    $1.6 billion$1.78 per share
    FY25

    Largely noncash and primarily related to actions within Optum. Important for setting a solid foundation for returning to historical earnings quality and growth.

    Domestic membership growth
    over 415,000 people
    FY25

    Contributed to 12% revenue growth in 2025.

    Medicare medical cost trend
    7.5%in line with expectation
    FY25

    Supports 2026 trend expectation of 10%.

    Medicare medical cost trend
    10%
    FY26

    Expected trend for 2026.

    Commercial medical trend
    approaching 11%
    FY26

    Reflects continued increases in care activity.

    ACA market margin
    about 1%plus or minus 1%
    FY26

    Pricing posture for 2026 is expected to return this market to a positive margin business.

    OptumRx customer savings
    more than $100 billion
    annually

    Generated through negotiations with drug manufacturers and network pharmacies.

    OptumRx member savings
    more than $1 billion
    annually

    Delivered through Price Edge and Specialty IQ solutions.

    OptumRx prior authorizations reduced
    more than 10%
    current

    Net effect of reducing overall prior authorizations by more than 10%.

    Optum Health total cost of care
    up to 30% bettervs competitors
    current

    Demonstrated in a large Texas market serving over 750,000 patients.

    Optum Health patient satisfaction NPS
    near 90
    current

    Demonstrated in a large Texas market serving over 750,000 patients.

    Optum Health mature value-based care patients in target margin range
    about 30%
    current

    Provides confidence in achieving long-term target margins for Optum Health.

    Medicaid rate increases
    6% to 7%
    FY26

    Expected for 2026, but will continue to be below medical trend.

    Industry KPIs

    9
    MetricValueDetails
    Utilization trends7.5%%
    Stars rate environmentdisappointing
    Medical loss care ratio88.8%%
    Client retention new winshigh 90s%
    Pharmacy scripts specialtyover 800clients
    Membership covered lives by line1.3 million to 1.4 millionmembers
    Segment revenue operating incomeapproximately 13%%
    Adjusted EPS EBITDA leverage guidancegreater than $17.75USD/share
    Medical cost trend vs pricing assumption10%%

    Deals & partnerships

    1
    VariousRemoved assets not aligned with the company's focus on serving the U.S. health system.

    The company has removed assets that are not aligned with its focus on serving the U.S. health system as part of its strategic refocus.

    Risks & headwinds

    6
    Medicare funding reductionsFY26, FY27

    $130 billion in funding reductions over the last 3 years; 2027 Advance Notice published yesterday simply doesn't reflect the reality of medical utilization and cost trends.

    Mitigation: Repriced insurance businesses, planned for MA membership contraction, will work with CMS to ensure appropriate final growth rate calculation.

    Ongoing funding shortfalls within state Medicaid programsFY26

    Incremental pressure in 2026; rate increases in the range of 6% to 7% in aggregate for the year, but that will continue to be below our medical trend.

    Mitigation: Received some rate relief, but still anticipate mismatch between rate and acuity. Expect Medicaid membership contraction.

    Rising medical cost trends / Elevated utilizationFY26

    Medicare medical cost trend of 7.5% in 2025, expected 10% in 2026. Commercial trend approaching 11%.

    Mitigation: Repriced insurance businesses, focused on margin recovery, AI-enabled operating efficiencies.

    Competitive market dynamics in Medicare AdvantageFY26

    Drove higher-than-expected plan shopping during the intensely competitive annual enrollment period, leading to 1.3 million to 1.4 million MA membership contraction.

    Mitigation: Strategy favored margin recovery over membership.

    Unaligned PPO contracts and non-viable sponsor contracts in Optum HealthMostly done for 2026, smaller amount still to address in 2027.

    Streamlined risk membership by approximately 15%.

    Mitigation: Dropped unaligned PPO contracts, repositioned certain markets, addressed payer de-delegation.

    Inconsistencies in market-to-market execution in Optum HealthPast, being addressed in 2026.

    In 2024 and 2025, inconsistencies in market-to-market execution hurt us.

    Mitigation: Intensely focused on driving consistency, accountability, and performance; consolidated EMRs.

    What to watch in Q1 FY26

    5

    Medicare Advantage 2027 Final Rate Calculation

    from now until the rates are finalized
    Current"disappointing" Advance Notice published
    Target"appropriate final growth rate calculation"

    Why it matters

    The final rate calculation will determine benefit reductions, choice, and access for seniors, significantly impacting UNH's MA footprint and benefits for 2027.

    We will continue to work with CMS to ensure an appropriate final growth rate calculation to avoid a profoundly negative impact on seniors' benefits and access to care.

    Q&A highlights

    5

    Is MA at the bottom of its cycle, will margins improve in 2027, and how important is MA to Optum Health?

    Management stated their 2026 MA strategy prioritized margin recovery (50 bps improvement) over membership, which is playing out as expected. The 2027 Advance Notice is 'disappointing' and will lead to 'meaningful benefit reductions' and potential for reduced choice/access, similar to 2026. It's too early for 2027 estimates, but the integrated model and value-based care will be crucial. MA is important to Optum, but Optum also complements UHC.

    Our 2026 approach favored margin recovery and these membership trends are a result of these actions.

    asked by Josh Raskin · answered by Timothy Noel

    3 min read6 chapters

    Detailed Narrative

    01

    Strategic Refocus and Operational Discipline

    UnitedHealth Group is undertaking a critical review of its products and U.S. market positions, focusing on optimizing its portfolio. This involves driving greater operational discipline across all business practices, leveraging technology and artificial intelligence broadly, and renewing commitment to innovation, agility, and accountability. The company has removed assets not aligned with its core focus on serving the U.S. health system and is strengthening its management team with internal talent and external expertise.

    02

    Optum Reorganization and Synergy

    Optum Financial Services has been strategically realigned from Optum Health into Optum Insight, effective 2026. This move aims to leverage greater synergy between health care technology and financial technology innovation. The integration, for example, of Optum Real's AI-driven revenue cycle solutions with Optum Financial Services' payment capabilities is expected to transform health care transactions, moving towards real-time point-of-care approval and monetization. This is anticipated to reduce processing friction, enhance Optum Insight's growth and margin potential, and create new value pools for payers.

    03

    Medicare Advantage Outlook and 2027 Advance Notice

    The 2027 Medicare Advance Notice, published recently, is viewed as 'disappointing' by management, as it implies further funding reductions for the program. This follows $130 billion in funding reductions over the last three years. The company anticipates that the current notice, if finalized, would lead to 'meaningful benefit reductions' and challenges in choice, access, and affordability for seniors. UnitedHealth Group plans to work with CMS to advocate for an appropriate final growth rate calculation, but expects potential modifications to plan footprint and benefits similar to 2026.

    04

    Optum Health Turnaround and Value-Based Care Focus

    Optum Health implemented substantial changes throughout 2025 to build a stronger foundation aligned with its integrated value-based care approach. Actions include narrowing its affiliated network by nearly 20%, streamlining risk membership by approximately 15% (by dropping unaligned PPO contracts and repositioning markets), and consolidating electronic medical records from 18 to 3 strategic EMRs. These efforts are aimed at improving execution consistency, accountability, and performance, with a goal of returning to strong, transparent, and consistent results while driving higher quality of care and lowering overall costs.

    05

    Transparency and Accountability Initiatives

    UnitedHealth Group is committed to advancing greater trust and transparency across its operations. This began with independent reviews of business practices and risk assessment in pharmacy services and care management, with remediation recommendations due by March. In 2026, the company will expand these efforts by publishing results in areas such as prior authorizations, claim approval rates, performance statistics, data and trends, rebate practices, and pricing for products and services. This initiative aims to increase public accountability for performance.

    06

    AI and Technology Investment for Productivity

    The company plans significant investments in modern intelligent technologies, with nearly $1.5 billion allocated for 2026 and at least as much expected in 2027. These investments are projected to drive nearly $1 billion in operating cost reductions in 2026, many of which are AI-enabled. AI tools are already being used in over 80% of member calls to answer questions faster and more accurately, allowing advocates to focus on providing better service. This technological focus is expected to serve as a foundation for external offerings through Optum Insight.

    AI-generated summary of the company’s earnings call. Not investment advice.